Analysys Of The Clinical Feature Of COPD Patients With Triple Therapy(ics/laba/lama)

被引：0
|
作者：
Miyazaki, M. [1 ]
Nakamura, H. [2 ]
Sasaki, M. [1 ]
Haraguchi, M. [1 ]
Chubachi, S. [1 ]
Takahashi, S. [1 ]
Yoshida, S. [3 ]
Shirahata, T. [4 ]
Asano, K. [5 ]
Betsuyaku, T. [1 ]
机构：
[1] Keio Univ, Tokyo, Japan
[2] Saitama Med Univ Hosp, Saitama, Japan
[3] Tokyo Med Ctr, Tokyo, Japan
[4] Saitama Social Insurance Hosp, Saitama, Japan
[5] Tokai Univ, Sch Med, Hiratsuka, Kanagawa, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4371
引用
收藏
页数：1
相关论文
共 50 条
  • [31] COPD Exacerbations And Pneumonia On Triple Therapy (fixed Ics/laba Combinations And Tiotropium). Does The Choice Of Ics/laba Matter?
    Johansson, G.
    Janson, C.
    Stallberg, B.
    Lisspers, K.
    Stratelis, G.
    Jorgensen, L.
    Larsson, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [32] Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD Cohort Study in Real-World Clinical Practice
    Suissa, Samy
    Dell'Aniello, Sophie
    Ernst, Pierre
    CHEST, 2020, 157 (04) : 846 - 855
  • [33] Factors influencing LAMA addition to COPD patients receiving ICS/LABA in clinical practice-RETRIEVE study
    Tryfon, Stavros
    Krommidas, Georgios
    Kapetangiorgis, Athanasios
    Bertoli, Maria
    Papanastasiou, Polyanthi
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [34] Triple (ICS/LABA/LAMA) vs. Dual (ICS/LABA) Therapy for Persistent, Uncontrolled Asthma: A Systematic Review and Meta-Analysis
    Kim, L.
    Saleh, C.
    Whalen-Browne, A.
    O'Byrne, P.
    Chu, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [35] Maintenance therapy in COPD: time to phase out ICS and switch to the new LAMA/LABA inhalers?
    Tariq, Syed Mohammad
    Thomas, Enson C.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 1877 - 1882
  • [36] Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis
    Koarai, Akira
    Yamada, Mitsuhiro
    Ichikawa, Tomohiro
    Fujino, Naoya
    Kawayama, Tomotaka
    Sugiura, Hisatoshi
    RESPIRATORY RESEARCH, 2021, 22 (01)
  • [37] Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis
    Akira Koarai
    Mitsuhiro Yamada
    Tomohiro Ichikawa
    Naoya Fujino
    Tomotaka Kawayama
    Hisatoshi Sugiura
    Respiratory Research, 22
  • [38] Evaluating multiple eosinophil measurements when stepping up to ICS/LAMA/LABA triple therapy in patients with COPD: a post-hoc analysis of ETHOS
    Singh, D.
    Bafadhel, M.
    Hurst, J. R.
    Darken, P.
    Patel, M.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [39] Single Inhaler Triple Therapy (ics/lama/laba) In Patients With Advanced COPD: Patient Reported Symptom And Inhaler Preference Results From The Fulfil Trial
    Tabberer, M.
    Lomas, D.
    Barnacle, H.
    Birk, R.
    Brealey, N.
    Zhu, C. -Q.
    Pascoe, S.
    Locantore, N.
    Lipson, D. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [40] Methodologic Issues With Comparative Effectiveness Study on LAMA-LABA-ICS vs LAMA-LABA for the Treatment of COPD in the Clinical Practice Research Datalink
    Suissa, Samy
    Dell'Aniello, Sophie
    Ernst, Pierre
    CHEST, 2020, 158 (02) : 832 - 833
12345